Latest Breaking News On - Melinda gates foundation collaboration - Page 1 : comparemela.com

Researchers Unveil Elusive HIV Protein Structure, Paving the Way for Targeted Treatments

Researchers Unveil Elusive HIV Protein Structure, Paving the Way for Targeted Treatments
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

Walther mothes at yale universityNational institute of allergyMelinda gates foundation collaborationNational institutes of healthMerkin institute professorDavid baltimore professorBiological engineeringMerkin instituteKim marie damChengcheng fanWalther mothesYale universityZhi yangNational institutesNational instituteInfectious diseases

Breakthrough Imaging Reveals HIV Protein Structures

Breakthrough Imaging Reveals HIV Protein Structures
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

National institutes of healthMelinda gates foundation collaborationNational institute of allergyMerkin institute professorWalther mothes at yale universityDavid baltimore professorBiological engineeringMerkin instituteKim marie damChengcheng fanWalther mothesYale universityZhi yangNational institutesNational instituteInfectious diseases

Nanoparticle HIV vaccine shows potential in trial

Positive first-in-human trial results have highlighted potential of a nanoparticle vaccine towards broadly neutralising against HIV.

Julie mcelrathAntibody centerNational institute of allergyDepartment of immunologyInfectious disease divisionMelinda gates foundation collaborationAntibody center at scripps researchRagon instituteScripps researchScience translational medicineSenior vice presidentFred hutchInfectious diseaseWilliam schiefExecutive directorNational institute

First-in-human nanoparticle HIV vaccine induces broad and publicly targeted helper T cell responses

Researchers from Fred Hutchinson Cancer Center in Seattle, Scripps Research in La Jolla, California, IAVI and other collaborating institutions have characterized robust T-cell responses in volunteers participating in the IAVI G001 Phase 1 clinical trial to test the safety and immune response of a self-assembling nanoparticle HIV vaccine.

United statesJulie mcelrathFred hutchLily ramseyAntibody center at scripps researchAntibody centerDepartment of immunologyRagon instituteScripps research in la jollaMelinda gates foundation collaborationNational institute of allergyScripps researchInfectious disease divisionFred hutchinson cancer centerScience translational medicineVaccine trials unit

New vaccine ingredient reveals promise

LA JOLLA, CA Scientists at La Jolla Institute for Immunology (LJI) and Massachusetts Institute of Technology (MIT), have found a possible way to

United statesShuhao xiaoJinal bhimanKristena rodriguesDianeg carnathanIvy phungSwati katariaMarianeb meloBenjamin cossetteShane crottyRuthm ruprechtAereas aungBrianl freemanDaniel lingwoodMurillo silvaJanw van wijnbergen